Related by context. Frequent words. (Click for all words.) 73 Tongjitang Chinese 68 Inc. Nasdaq SEPR 66 MDCO 65 Company Nasdaq PRGO 63 Warner Chilcott Limited 63 Small Molecules 62 CRTX 62 Inc Therapeutic Competitors 62 Inc. Nasdaq IMGN 61 NYSE SGP 61 NASDAQ SVNT 60 VRUS 60 Transcept Pharmaceuticals 60 Inc. Nasdaq MYL 60 Connetics Corporation 60 Sciele Pharma Inc. 59 DRRX 59 Nasdaq ADLR 59 Questcor Pharmaceuticals Inc. 59 LGND 59 Initiates Phase II 58 Inc. NASDAQ MRNA 58 Penwest Pharmaceuticals 57 Bovie Medical Corporation 57 Abbott ABT 57 LeMaitre Vascular Inc. 57 AKRX 57 Inc. NASDAQ SNTS 57 Progenics Pharmaceuticals 56 NYSE MYL 56 Inc. Nasdaq ESRX 56 CADX 56 Teleflex Incorporated 56 Bearish Pressure Building 56 Explore Strategic Alternatives 56 Calls Purchased 56 China Aoxing Pharmaceutical 56 Inc. NASDAQ QLTI 56 Presents Positive 56 Generic Version 56 Trend Continues Down 56 CHTT 56 Paladin Labs 56 Q1 Loss Narrows 56 Q3 Loss Narrows 56 Neose Technologies Inc. 55 Q1 Loss Widens 55 Cerus Corporation 55 Barrier Therapeutics Inc. 55 DEERFIELD Ill. BUSINESS WIRE 55 ICOS Corporation 55 Q2 Loss Widens 55 Options Trader Alert 55 Files Shelf Registration Statement 55 CEO Exercises Options 55 Q2 Loss Narrows 55 Hold Third Quarter 55 Omrix Biopharmaceuticals Inc. 55 NASDAQ TEVA 55 Enzon Pharmaceuticals 55 Webcast Annual Meeting 55 PROFILE CO 55 Tibotec Pharmaceuticals 55 Q4 Loss Widens 55 PRGO 55 Report companiesandmarkets.com adds 55 Completes Enrollment 55 GlaxoSmithKline plc GSK 55 DVAX 55 Nasdaq AMGN 54 Inc. Nasdaq ARNA 54 Subsidiaries Consolidated Statement 54 quotes/comstock/# * 54 Q1 Profit Surges 54 Q4 Loss Narrows 54 Stock Upgraded 54 Synergy Pharmaceuticals 54 Interesting Options Volume 54 www.gsk.com 54 Q2 Profit Surges 54 Earnings Scorecard 54 Beats Analyst 54 F#Q# Qtr End 54 MNTA 54 Adeona Pharmaceuticals Inc. 54 Stock Downgraded 54 www.schering plough.com 54 Idera Pharmaceuticals 54 Q3 Loss Widens 53 Fresenius Kabi AG 53 Completes Tender Offer 53 IPXL 53 Guides FY# Quick Facts 53 Q4 Profit Surges 53 Nasdaq BDSI 53 FDA Clears 53 Q2 Profit Declines 53 AUXL 53 Affymax Inc. 53 Targanta Therapeutics 53 Welcomes Analyst